Proteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 1809-1822

  Perluigi, Marzia ^a   Giorgi, Alessandra ^a   Blarzino, Carla ^a   De Marco, Federico ^b   Foppoli, Cesira ^c   Di Domenico, Fabio ^a   Butterfield, D Allan ^d   Schininà, M Eugenia ^a   Cini, Chiara ^a   Coccia, Raffaella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cervical carcinoma; HPV; Oxidative stress; Proteomics

Indexed keywords

PROTEIN;

ARTICLE; CELL LINE; HUMAN; KERATINOCYTE; MASS SPECTROMETRY; METABOLISM; OXIDATION REDUCTION REACTION; PAPILLOMA VIRUS; PHYSIOLOGY; PROTEOMICS; RADIATION EXPOSURE; TWO DIMENSIONAL GEL ELECTROPHORESIS; ULTRAVIOLET RADIATION; VIROLOGY; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TRANSFORMED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; KERATINOCYTES; OXIDATION-REDUCTION; PAPILLOMAVIRIDAE; PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; ULTRAVIOLET RAYS;

HUMAN PAPILLOMAVIRUS;

EID: 72949108915     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00465.x     Document Type: Article

References (60)

1. Valko M, Rhodes CJ, Moncol J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006 160 : 1 40.
2. Karihtala P, Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. Apmis. 2007 115 : 81 103.
3. Halliwell B. Oxidative stress and cancer: have we moved forward Biochem J. 2007 401 : 1 11.
4. D'Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 2007 8 : 813 824.
5. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal. 1999 11 : 1 14.
6. Ryter SW, Kim HP, Hoetzel A, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007 9 : 49 89.
7. Toyokuni S, Okamoto K, Yodoi J, et al. Persistent oxidative stress in cancer. FEBS Lett. 1995 358 : 1 3.
8. Storz P. Reactive oxygen species in tumor progression. Front Biosci. 2005 10 : 1881 1896.
9. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991 51 : 794 798.
10. Saeki K, Kobayashi N, Inazawa Y, et al. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Biochem J. 2002 368 : 705 720.
11. Kim SW, Han YW, Lee ST, et al. A superoxide anion generator, pyrogallol, inhibits the growth of HeLa cells via cell cycle arrest and apoptosis. Mol Carcinog. 2008 47 : 114 125.
12. Ozben T. Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci. 2007 96 : 2181 2196.
13. Hensley K, Robinson KA, Gabbita SP, et al. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med. 2000 28 : 1456 1462.
14. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002 2 : 342 350.
15. Fehrmann F, Laimins LA. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene. 2003 22 : 5201 5207.
16. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000 92 : 690 698.
17. De Marco F, Perluigi M, Foppoli C, et al. UVB irradiation down-regulates HPV-16 RNA expression: implications for malignant progression of transformed cells. Virus Res. 2007 130 : 249 259.
18. Levine RL, Williams JA, Stadtman ER, et al. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1994 233 : 346 357.
19. Maurer HH, Peters FT. Toward high-throughput drug screening using mass spectrometry. Ther Drug Monit. 2005 27 : 686 688.
20. Mignogna G, Giorgi A, Stefanelli P, et al. Inventory of the proteins in Neisseria meningitidis serogroup B strain MC58. J Proteome Res. 2005 4 : 1361 1370.
21. Pappin DJ. Peptide mass fingerprinting using MALDI-TOF mass spectrometry. Methods Mol Biol. 2003 211 : 211 219.
22. Lauderback CM, Hackett JM, Huang FF, et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem. 2001 78 : 413 416.
23. Conrad CC, Talent JM, Malakowsky CA, et al. Post-electrophoretic identification of oxidized proteins. Biol Proced Online. 2000 2 : 39 45.
24. Maurer MH, Feldmann RE Jr., Bromme JO, et al. Comparison of statistical approaches for the analysis of proteome expression data of differentiating neural stem cells. J Proteome Res. 2005 4 : 96 100.
25. Butterfield DA, Castegna A. Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders. Amino Acids. 2003 25 : 419 425.
26. Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol. 1997 10 : 485 494.
27. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995 87 : 796 802.
28. Prasad S, Soldatenkov VA, Srinivasarao G, et al. Intermediate filament proteins during carcinogenesis and apoptosis (Review). Int J Oncol. 1999 14 : 563 570.
29. Barak V, Goike H, Panaretakis KW, et al. Clinical utility of cytokeratins as tumor markers. Clin Biochem. 2004 37 : 529 540.
30. Nagai T, Murota M, Nishioka M, et al. Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: its clinical significance. Eur J Gastroenterol Hepatol. 2001 13 : 157 161.
31. Gharib TG, Chen G, Wang H, et al. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia. 2002 4 : 440 448.
32. Prasad SC, Soldatenkov VA, Kuettel MR, et al. Protein changes associated with ionizing radiation-induced apoptosis in human prostate epithelial tumor cells. Electrophoresis. 1999 20 : 1065 1074.
33. Calderwood SK, Khaleque MA, Sawyer DB, et al. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 2006 31 : 164 172.
34. Kimura E, Enns RE, Thiebaut F, et al. Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell line. Cancer Chemother Pharmacol. 1993 32 : 279 285.
35. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst. 2000 92 : 1564 1572.
36. Aghdassi A, Phillips P, Dudeja V, et al. Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res. 2007 67 : 616 625.
37. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005 10 : 86 103.
38. Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol. 2003 21 : 255 261.
39. Spickett CM, Pitt AR, Morrice N, et al. Proteomic analysis of phosphorylation, oxidation and nitrosylation in signal transduction. Biochim Biophys Acta. 2006 1764 : 1823 1841.
40. Dean RT, Fu S, Stocker R, et al. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J. 1997 324 : 1 18.
41. Stadtman ER. Protein oxidation and aging. Science. 1992 257 : 1220 1224.
42. Smith CD, Carney JM, Starke-Reed PE, et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA. 1991 88 : 10540 10543.
43. Butterfield DA, Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev. 2001 122 : 945 962.
44. Perluigi M, Poon HF, Maragos W, et al. Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease. Mol Cell Proteomics. 2005 4 : 1849 1861.
45. Ling M, Merante F, Chen HS, et al. The human mitochondrial elongation factor tu (EF-Tu) gene: cDNA sequence, genomic localization, genomic structure, and identification of a pseudogene. Gene. 1997 197 : 325 336.
46. Janssen GM, Morales J, Schipper A, et al. A major substrate of maturation promoting factor identified as elongation factor 1 beta gamma delta in Xenopus laevis. J Biol Chem. 1991 266 : 14885 14888.
47. Mimori K, Mori M, Tanaka S, et al. The overexpression of elongation factor 1 gamma mRNA in gastric carcinoma. Cancer. 1995 75 : 1446 1449.
48. Lee JM. The role of protein elongation factor eEF1A2 in ovarian cancer. Reprod Biol Endocrinol. 2003 1 : 69.
49. Tomlinson VA, Newbery HJ, Wray NR, et al. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. BMC Cancer. 2005 5 : 113.
50. Ding Q, Markesbery WR, Chen Q, et al. Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci. 2005 25 : 9171 9175.
51. Waisman DM. Annexin II tetramer: structure and function. Mol Cell Biochem. 1995 149-150 : 301 322.
52. Moss SE. Annexins. Trends Cell Biol. 1997 7 : 87 9.
53. Mai J, Waisman DM, Sloane BF. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim Biophys Acta. 2000 1477 : 215 230.
54. Tanaka T, Akatsuka S, Ozeki M, et al. Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene. 2004 23 : 3980 3989.
55. Ozaki T, Sakiyama S. Molecular cloning of rat calpactin I heavy-chain cDNA whose expression is induced in v-src-transformed rat culture cell lines. Oncogene. 1993 8 : 1707 1710.
56. Choi J, Conrad CC, Dai R, et al. Vitamin E prevents oxidation of antiapoptotic proteins in neuronal cells. Proteomics. 2003 3 : 73 7.
57. Butterfield DA, Perluigi M, Sultana R. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol. 2006 545 : 39 50.
58. Cabiscol E, Piulats E, Echave P, et al. Oxidative stress promotes specific protein damage in Saccharomyces cerevisiae. J Biol Chem. 2000 275 : 27393 27398.
59. Castegna A, Aksenov M, Thongboonkerd V, et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem. 2002 82 : 1524 1532.
60. Tamarit J, Cabiscol E, Ros J. Identification of the major oxidatively damaged proteins in Escherichia coli cells exposed to oxidative stress. J Biol Chem. 1998 273 : 3027 3032.